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Background: The Liverpool Oral Rehabilitation Questionnaire version 3 (LORQv3) is a measure assessing the impact
of oral rehabilitation on patients’ health-related quality of life (HRQOL).The aims of the study were to adapt culturally
the LORQv3 for Turkish-speaking head and neck cancer patients who had undergone prosthetic rehabilitation and
to undertake an initial investigation of its psychometric properties.
Methods: The Turkish version of the LORQv3 was translated and culturally adapted into Turkish, and tested on a
sample of 46 head and neck cancer patients who had undergone prosthetic rehabilitation at a university clinic. Patients
were categorized into three groups: Patients with maxillary obturator prostheses treated by surgery alone (n = 15);
Patients with maxillary obturator prostheses treated by surgery plus radiotherapy, with or without chemotherapy
(n = 23); and, Nasopharyngeal cancer patients without maxillary defects wearing conventional dental prostheses
who had been treated by radiotherapy with or without chemotherapy (n = 8). Data were collected through clinical
examinations and self-reported questionnaires, including socio-demographic characteristics, the LORQv3, and the
University of Washington Quality of Life questionnaire version 4 (UW-QOLv4). The psychometric evaluation included
validity (content, face, construct, and criterion) and reliability (internal consistency and test-retest).
Results: All sections of the LORQv3 showed satisfactory internal consistency, with Cronbach’s alpha between 0.71 to
0.82. Kappa statistics showed moderate to perfect test-retest reliability for the 33 LORQv3 items. We found significant
negative correlations between the LORQv3 and the UW-QOL v4 for some related items. The LORQv3 also identified
differences in responses among patient groups, supporting its construct and criterion validity.
Conclusions: This study provides initial evidence in support of the validity and reliability of the Turkish version of
LORQv3 in prosthetically rehabilitated patients with head and neck cancer; it could be used in clinical practice in Turkey.
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In recent years, there has been increasing recognition
that health-related quality of life measures (HRQOL)
play an important role for assessing clinically significant
changes in cancer patients and the comparative effective-
ness of different treatments [1,2]. Following treatment,
patient concerns shift from survival towards improvement* Correspondence: kpeker@istanbul.edu.tr
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unless otherwise stated.and maintenance of the HRQOL [3]. In this period, oral
rehabilitation is a cornerstone of efforts to restore patients’
orofacial form and function, assisting them to face func-
tional, psychosocial and aesthetic problems that affect
general well-being [1,3,4].
Generic HRQOL measures are commonly used in a
combination with head and neck cancer and oral health
specific HRQOL measures in many studies assessing treat-
ment outcomes of oral rehabilitation on patients’ HRQOL
[5-11]. A recent consensus report on orofacial rehabilita-
tion [12] states that more sensitive and specific measurestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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on patients’ HRQOL, because the existing measures seem
to lack discriminating ability to measure the effects of oral
rehabilitation on HRQOL in these cases. In this context,
the Liverpool Oral Rehabilitation Questionnaire (LORQ)
is a recently developed HRQOL measure that deal specif-
ically with oral rehabilitation for patients with head and
neck cancer [13,14]. This measure was designed to identify
issues and problems pertaining to the oral rehabilitation of
patients within the context of the patients’ overall HRQOL
[14]. Since its publication in 2004, the questionnaire has
been modified to include more detailed questions on oral
function and patients’ dental and prosthetic status, result-
ing in the LORQ version 3 (LORQ v3) [15]. The LORQv3
has been validated for both dental patients attending gen-
eral dental practices and patients attending the oral re-
habilitation clinic [15-17].
In Turkey, demand for cancer treatment has been rising
because of the increasing trends in cancer rates [18]. To
our knowledge, there are no published studies that have
evaluated the impacts of oral rehabilitation on head and
neck cancer patients’ HRQOL using head and neck cancer
specific measures in Turkey. The aims of this study were
to carry out the cultural adaptation of the LORQv3
into Turkish and to assess its reliability and validity in
patients with head and neck cancer who underwent
oral rehabilitation.
Methods
The study was performed in two stages. In the first
stage, the scale was translated into Turkish and adapted
to Turkish culture. In the second stage, the psychomet-
ric properties of the LORQv3 was evaluated.
Translation and adaptation process
We followed the six steps described by Beaton et al. [19],
intended for questionnaires of self-report health measures,
as follows:
Stage 1- Two independent native Turkish speaking
translators were used to translate the LORQv3 into
Turkish. One of the translators was a clinician and
therefore aware of the concepts that are being measured
with the LORQv3 and the other translator was a lan-
guage specialist without medical background.
Stage 2- The two translators met to discuss their work,
and agreed on a common Turkish version.
Stage 3- Two different back-translations were per-
formed by English, by two independent English native
spoken non-medical translators.
Stage 4- An expert committee consisting of a method-
ologist-biostatistician, four oral health professionals (den-
tal public health, prosthetic dentistry, oral surgery), one
linguist and four translators evaluated all reported data.
They developed the “pre-final version” of the LORQv3,considering semantic, idiomatic, experiential, and concep-
tual equivalence. In addition, the face and content validity
of the scale were examined by the expert panel in order to
assess the clarity of the item wording. At this stage, we
contacted the developers of the LORQv3 to avoid misun-
derstanding and to use correct terminology regarding the
term ‘implant retained teeth’. We changed the term ‘im-
plant retained teeth’ to ‘implant retained crown, bridge or
denture’ to increase conceptual and semantic equivalence
in all related items. To facilitate comprehension, Item 9
‘Did you have problems drooling?’ was modified to ‘Did
the saliva dribble out of the edge of your mouth? and Item
11, ‘Were you upset by your facial appearance?’ was modi-
fied to ‘Were you concerned by the appearance of your
face?’. To increase conceptual equivalence, Item 15, ‘Did
your chewing ability affect your social life?’ was modified
to ‘Did you avoid spending time with others in social ac-
tivities because of your chewing problems?’ and Item 16
‘Did your chewing ability influence your choice of foods?’
was modified to ‘Did you have a preference for some foods
because of your chewing problems?’. The term ‘ulceration’
was translated as ‘any soreness or injury to the gum’ to in-
crease comprehension (Items 27 and 35).
Stage 5- This version was tested on a convenience
sample of 12 patients with head and neck cancer to
guarantee sensitivity to local culture and selection of the
appropriate wording.
Stage 6- Final version of the LORQv3 was sent to the




The Turkish version of the LORQv3 was tested in a
sample of 46 head and neck cancer patients who under-
went oral rehabilitation at the Prosthodontics Clinic of
our faculty between January 2008 and December 2010.
The sample size was calculated based on the test-retest
reliability, which was estimated using weighted kappa.
The sample size required that weighted kappa be esti-
mated to be 32, using Cicchetti's Formula: n = 2 k2,
where k is the number of response categories [20]. In
order to allow a 20% drop-out between testing and re-
testing, at least 38 participants had to be invited.
Participants were retrospectively identified from the
patient record information database. Eligibility criteria
for participants were: (1) aged 18 years or older; (2) to
have received prosthetic rehabilitation with definite ob-
turator prosthesis or conventional prosthesis following
cancer treatment; (3) to have been wearing a obturator
prosthesis or conventional prosthesis for at least six
months; (4) to be disease free at the time of the question-
naire; (5) not to have undergone mandibulectomy nor
glossectomy; and (6) to be able to read Turkish. Patients
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before the HRQOL assessment were excluded.
Sixty-three cancer patients who met these criteria were
identified and contacted via telephone by a research as-
sistant. At this initial contact, the research assistant ex-
plained the study to the patients and asked them to
participate in a research study. Four of these persons
had died, five were living too far away, three had con-
tinuing or recurrent disease, and five did not want to
participate in this study and therefore were not included.Procedure
This study was approved by the Ethics Committee of the
Faculty of Medicine, the University of Istanbul (Approval
number: 2011/502-494), and the patients gave their writ-
ten consent. Patients who agreed to participate in the
study and to visit the clinic twice were invited to our
clinic for interviews and clinical examinations. At the
first appointment, the charts of enrolled patients were
reviewed, and demographic, tumor, and treatment data
were collected. The patients were examined by a prostho-
dontist (A.B.) to assess the size of maxillectomy defect and
the status of the dentition. Following examination, ques-
tionnaires were administered by a single research assistant
(M.O.K.) in the waiting room. For test-retest reliability, all
patients filled the LORQv3 twice at 7-14 days intervals in
the same waiting room. No treatment was given to the
study participants during this two-week period.Questionnaire
The questionnaire consisted of the LORQv3, the Univer-
sity of Washington Quality of Life questionnaire version
4 (UW-QOL v4), and a socio-demographic section.
The LORQv3 was developed by Pace-Balzan et al. [15]
and consists of 40 items divided into two primary sec-
tions. The first 17 items assess issues related to oral
function, orofacial appearance and social interaction.
The remaining items deal with prostheses and patient
denture/prosthetic satisfaction. Items refer to problems
or symptoms experienced during the previous week and
are rated on a 1–4 Likert scale ranging from never (1) to
always (4).
The UW-QOL v4 is a valid and reliable tool specific-
ally designed to assess the quality of life of patients with
head and neck malignancies [21]. The UW-QOL v4 con-
sist of 12 disease-specific items divided into two sub-
scales: physical function (chewing, swallowing, speech,
taste, saliva, and appearance) and social-emotional func-
tion (anxiety, mood, pain, activity, recreation, and shoulder
function). Each item is scored from 0 (worst HRQOL) to
100 (best HRQOL). The validity and reliability of the
Turkish version of the UW-QOL v4 was tested by Şenkal
et al. [22].Statistical analysis
Descriptive data included mean values and standard de-
viation for continuous variables and proportions for
categorical variables. Face and content validity of the
questionnaire were examined by the expert panel prior
to the validation. Reliability was assessed in two ways:
internal consistency reliability and test–retest reliability.
Internal consistency was evaluated with Cronbach's alpha
coefficient. Test- retest reliability, with a 7–14-day interval
between test and retest, was measured by the kappa coeffi-
cient weighted by applying standard weights according to
the number of categories in error. Internal consistency is
considered good if Cronbach’s alpha approximates to 0.70
but does not exceed 0.90, which implies the presence of
redundant items [23]. Kappa values between 0.00 and 0.20
are considered poor; those between 0.21 and 0.40, fair;
those between 0.41 and 0.60, moderate; those between
0.61 to 0.80, good; and those between 0.81 and 1.00, very
good [24].
Criterion validity was assessed by the following hypoth-
eses: (1) Significant negative correlations (Spearman’s rank
order correlation coefficient) would be found between
items of the LORQv3 and the UW-QOL v4 that assess the
related function. (2) Items of the LORQv3, assessing the
psychosocial impact of prostheses and the participant’s
denture satisfaction would be more correlated with the
items in the physical subscale of the UW-QOL v4 than
the terms in the social–emotional function subscale of
the UW-QOL v4. Interpretation of correlation coeffi-
cients was as follows: r ≤0.49: weak relationship; 0.50 ≤
r ≤0.74: moderate relationship; and r ≥0.75: strong rela-
tionship [25].
Construct validity was evaluated by comparing item
scores of the LORQv3 among patient groups who re-
ceived different oral rehabilitations. It is known that
postoperative radiation therapy and the extent of therapy
are most important variables affecting HRQOL in max-
illectomy patients with prosthetic obturation [5,6,8,9].
Oral cancer survivors had more problems regarding
social eating, social contact, and opening the mouth than
nasopharyngeal cancer survivors [26]. Thus, patients were
classified into three groups: 15 patients rehabilitated with
maxillary obturator prostheses after maxillectomy; 23 pa-
tients rehabilitated with maxillary obturator prostheses
who were treated with surgery plus postoperative radio-
therapy, with or without chemotherapy; 8 nasopharyngeal
cancer patients without maxillary defects wearing a con-
ventional upper denture, who served as a control group.
We hypothesized that: (1) Maxillary obturator patients
would report higher scores on the items related to facial
appearence, speaking, and dissatisfaction with the upper
denture than nasopharynx cancer patients wearing con-
ventional upper dentures; (2) Maxillary obturator patients
treated with surgery plus radiotherapy with or without
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and emotional problems with their upper prosthesis than
those who had been treated with surgery alone and who
had been diagnosed with nasopharyngeal cancer.
In order to compare the socio-demographic and clinical
characteristics of patient groups, continuous data were ana-
lyzed by means of analysis of variance (one-way ANOVA),
Kruskal-Wallis, Mann- Whitney U and independent- sam-
ple t-tests. The continuous variables were tested for nor-
mal distribution by the Shapiro-Wilk test. Categorical
variables were examined using the chi-square test. Fisher’s
exact test was used for variables with expected counts <5.
To verify differences on LORQv3 scores between groups,
we used the non-parametric Kruskal-Wallis test with
Dunn's multiple comparison post test. Statistical analyses
were performed with SPSS Statistics version 19.0.0 (IBM
Corporation, Somers, NY, USA). Linear weighted kappa
was calculated according to the procedure given on the














Marital statusa (n, %)
Single, divorced, or widowed 3 (20)
Married 12 (80)
Employment Statusa (n, %)
Employed full-time/part-time 5 (33.3)
Unemployed 10 (66.7)




Educational levela (n, %)
≤ 8 years of schooling 9 (60)





Class ≤2 b 8 (53.3)
Class >2 b 7 (46.7)
SD, standard deviation; TRY, Turkish Lira; aStatistical evaluation by the chi-square te
the Kruskal-Wallis test.Results
Study sample description
The socio-demographic and clinical characteristics of
participant groups are shown in Table 1. Of the 46 pa-
tients with a mean age of 52.76 ± 12.89 years (range 18-
77 years), 8 (17%) had cancers of the nasopharynx and
38 (83%) had cancers of the maxillary sinus. Men made
up 63% (n = 29) of the participants; 83% (n = 38) were
married; 33% (n = 15) were employed; and 61% (n = 38)
had formal school education equal to or less than 8 years.
Of the 38 patients with maxillary sinus cancer, 15 (39%)
had surgery alone, and 7 (18%) had undergone a facial
approach. According to the Brown et al. [27] classifica-
tion, maxillectomy defects were Class IIb or smaller in
45% (n = 17) and larger than Class IIb in 55% (n = 21) of
patients. Tumor classification, according to the American
Joint Committee on Cancer (AJCC) staging system, was
T1 in 3 patients, T2 in 14 patients, T3 in 16 patients, and











n = 23 n = 8
12 (52.2) 6 (75) 0.311
11 (47.8) 2 (25)
4 (17.4) 1 (12.5) 0.903
19 (82.6) 7 (87.5)
9 (39.1) 1 (12.5) 0.383
14 (60.9) 7 (87.5)
9.21 (11.06) 52.76 (12.89) 0.145
3.91 (1116.93) 923.75 (281.21) 0.226
14 (60.9) 5 (62.5) 0.993
9 (39.1) 3 (37.5)
18 (78.3) - 0.514
5 (21.7)
9 (39.1) - 0.389
14 (60.9)
st; bStatistical evaluation by the one-way ANOVA test; cStatistical evaluation by
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tients (data not shown).
According to the AJCC classification staging system for
nasopharyngeal carcinoma, three patients (38%) had T1, 3
(38%) had T2, one (12%) had T3 and one (12%) had T4 tu-
mors. Two patients (25%) had N0, four (50%) had N1, and
two (25%) had N2. Three patients (37%) were treated with
radiotherapy alone and five patients (63%) were treated
with radiotherapy plus chemotherapy (data not shown).
There were no statistically significant differences among
all patient groups with regards to socio-demographic char-
acteristics. Additionally, no significant differences were
found in demographic and clinical characteristics between
the two groups of patients rehabilitated with a maxillary
obturator.Table 2 The differences for the first 17 LORQv3 items assessin







1 Did you experience difficulty chewing? 2.26
2 Did you have pain when you chew? 2.00
3 Did you experience difficulty swallowing solids?* 1.60
4 Did you experience difficulty swallowing drinks? 1.86
5 Did food particles collect under your tongue? 1.33
6 Did food particles stick to your palate? 2.20
7 Did food particles stick inside your cheeks? 1.73
8 Did you have mouth dryness?** 1.80
9 Did the saliva dribble out of the edge of your
mouth?
1.46
10 Did you have problems when speaking?* 2.20
11 Were you concerned by the appearance of
your face?**
2.06
12 Were you concerned by the appearance of
your mouth?
2.00
13 Were you upset by the appearance of your lips? 1.60
14 Were you upset by the appearance of your
teeth?
1.73
15 Did you avoid spending time with others in
social activities because of your chewing
problems?
1.93
16 Did you have a preference for some foods
because of your chewing problems?
2.00
17 Did you experience difficulty with opening
your mouth?***
1.20
SD, standard deviation; Kruskal-Wallis test for differences between 3 groups: *P < 0.
following significant differences among groups at p <0.05 significance level: Group
Group C, Group B vs Group C for item 8, Group B vs Group C for item 10; Group A
vs Group C for item 17.Psychometric properties of the LORQv3
Cronbach’s alpha for internal consistency of items was
0.82 for the first 17 LORQv3 items. For Items 20–23,
Cronbach’s alpha was 0.72, for Items 26–31 alpha was
0.77 and for Items 34–39 alpha was 0.71.
The first 17 items of the LORQv3 assessed issues relat-
ing to oral function, orofacial appearance and social
interaction and were applicable to all patients (Table 2).
All maxillary sinus cancer patients were rehabilitated
with conventional obturator prostheses. There were rela-
tively fewer nasopharyngeal cancer patients with natural
teeth in their upper jaw than patients with maxillary
sinus cancer. More than half of the patients in each
group still had natural teeth in either the upper or the














n = 23 n = 8
SD Mean SD Mean SD
1.16 2.69 0.97 2.75 1.28
1.33 1.95 0.70 1.75 1.16
0.91 2.39 1.03 2.62 1.18
0.99 1.65 0.93 1.87 1.12
0.82 1.47 0.73 1.75 0.70
0.94 2.22 0.85 2.12 1.12
0.96 1.86 0.75 2.00 1.19
0.67 2.86 1.05 3.00 1.30
0.91 1.91 0.84 1.37 0.74
0.94 2.47 0.94 1.50 0.53
1.16 2.21 0.95 1.12 0.35
1.06 2.04 1.06 1.50 0.75
1.12 1.95 0.97 1.37 0.51
0.96 1.74 1.09 1.37 0.74
0.96 1.78 1.08 2.00 1.06
1.06 2.30 1.01 2.75 1.28
0.41 2.60 1.07 3.12 0.83
05, **P < 0.01, ***P < 0.001. Post hoc comparisons using Dunn's test revealed
A vs Group B, Group A vs Group C for item 3; Group A vs Group B, Group A vs
vs Group C, Group B vs Group C for item 11; and Group A vs Group B, Group A
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(Table 3).
Regarding construct validity, we found significant dif-
ferences in some items related to swallowing solid, dry
mouth, speaking, facial appearance and mouth opening
among patient groups. Maxillary obturator patients who
received surgery alone scored better than those with
radiotherapy on three items: mouth dryness, difficulty
with swallowing solids, and opening the mouth. Differ-
ences between maxillary obturator patients and naso-
pharyngeal cancer patients were specific to certain items
and were consistently worse for the maxillary obturator
patients - problems when speaking and concern about
facial appearance. Nasopharyngeal cancer patients re-
ported more difficulties with mouth dryness (xerosto-
mia) and opening the mouth (Table 2).
The second part of the LORQv3 assessed the social
impact of prostheses and the patient’s denture satisfac-
tion. Maxillary obturator patients who received surgery
alone reported less difficulty with opening mouth than
patients who had received radiotherapy (Table 4).
For items 26 to 31, referring to maxillary dentures or
implant-retained teeth, maxillary obturator patients gener-
ally felt more dissatisfied and insecure than nasopharynx
cancer patients without any maxillary defects. Compared
with nasopharyngeal cancer patients, maxillary obturator
patients who received surgery plus radiotherapy felt more
concerned about their dentures and reported having sore-
ness or injury to the gums due to their dentures; they were
the most likely to find food collecting under their dentures
(Table 5).
For items 34 to 39, concerning mandibular dentures








18. Do you have any natural teeth in the UPPER jaw? 67 10/1
19. Do you have any natural teeth in the LOWER jaw? 80 12/1
Natural teeth in either upper or lower jaw 53 8/15
24. Do you have an UPPER denture? 100 15/1
25. Do you have UPPER implant retained crown,
bridge or denture? 0
Upper denture or implant retained teeth 100 15/1
32. Do you have a LOWER denture? 60 9/15
33. Do you have LOWER implant retained crown,
bridge or denture?
0
Lower denture or implant retained teeth 60 9/15who received radiotherapy felt more worried about their
lower dentures and were the most likely to find food col-
lecting under these and to have soreness or gingival in-
jury than maxillary obturator patients who received
surgery alone (Table 6).
All patients participated in the test-retest, with a 10-
day median interval (interquartile range: 8 to 12 days).
For the 33 LORQ items, kappa ranged from 0.62 to 1.00,
which represents 'good' to 'perfect’ agreement and none
demonstrated poor or fair agreement. In the first section
of the LORQv3, all items showed good to perfect agree-
ment. Of the 16 items in the second section of the
LORQv3, only seven had good agreement, with the
remaining nine items having “perfect” agreement. For
the 33 LORQ items, median kappa was 0.79, interquar-
tile range was 0.71 to 0.85, and range was 0.62 to 1.00.
Median kappa for the first 17 items was 0.75 and for the
other items, 0.84 (data not shown).
Criterion validity was supported via correlations for some
related items between the LORQv3 and the UW-QOL v4
(Table 7). Out of a total of 396 correlations, we found a
total of 96 statistically significant negative correlations be-
tween the LORQv3 items and the UW-QOL v4 item
scores (median –0.39, interquartile range (IQR) –0.44 to –
0.34). Consistent with the first hypothesis, moderate to
weakly significant correlations were observed for some re-
lated domains between the LORQv3 and the UW-QOL
v4: The UWQoLv4 appearance item correlated with all
LORQv3 items (Items 11,12,13 and 14) concerning ap-
pearance (range of r = –0.30 to –0.51; P < 0.05 to P <0.01);
the UWQoLv4 saliva item correlated with some LORQv3
items (Items 3,5,8,16,17,23,31,35, 36 and 39) about the















n = 23 n = 8
% n % n
5 52 12/23 63 5/8
5 87 20/23 50 4/8
52 12/23 50 4/8
5 100 23/23 100 8/8
0 0
5 100 23/23 100 8/8
43 10/23 50 4/8
0 0
43 10/23 50 4/8
















n = 15 n = 23 n = 8
Mean SD Mean SD Mean SD
If dentures or implant retained crown, bridges or dentures
(YES to question 24, 25, 32 or 33)
20. Were you embarrassed talking with others because
of your dentures/implant retained crown, bridges
or dentures? 1.86 0.83 1.47 0.94 1.62 0.74
21. Did you refuse dinner invitations because of feeling
embarrassed about your dentures/implant retained
crown, bridges or dentures? 1.60 0.63 1.73 1.09 2.00 1.06
22. Did you feel loss of self-confidence because of
embarrassment about your dentures/implant retained
crown, bridges or dentures?
1.46 0.51 1.34 0.48 1.25 0.46
23. Did you have difficulty opening mouth because of your
dentures/implant retained crown, bridges or dentures?***
1.20 0.41 2.17 0.83 2.25 0.46
SD, standard deviation; Kruskal-Wallis test for differences between 3 groups: ***P < 0.001. Post hoc comparisons using Dunn's test revealed following significant
differences among groups at p <0.05 significance level: Group A vs Group B, Group A vs Group C for item 23.
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lated with all LORQv3 items related to chewing problems
(range -0.43 to -0.60; P <0.01); the UWQoLv4 swallowing
item correlated with Item 3 about swallowing (r = –0.65;








If upper dentures or implant retained crown, bridges or
dentures (YES to question 24 or question 25)
26. Were you dissatisfied with your upper denture/implant
retained crown, bridges or dentures?**
2.66
27. Did your upper denture/ implant retained crown,
bridges or dentures cause any soreness or injury to the
gum?**
2.20
28. Did food particles collect under your upper denture/
implant retained crown, bridges or dentures?*
2.53
29. Did you take out your upper denture/implant retained
crown, bridges or dentures for eating?
1.53
30. Did you feel anxious with your upper denture/implant
retained crown, bridges or dentures?**
2.53
31. Were you worried about your upper denture/implant
retained crown, bridges or dentures?*
2.26
SD, standard deviation; Kruskal-Wallis test for differences between 3 groups: *P < 0.
significant differences among groups at p <0.05 significance level: Group A vs Grou
vs Group C for item 28; Group A vs Group C, Group B vs Group C for item 30; Grouswallowing Items 3 and 4 of the LORQv3 (r = –0.38;
P <0.01 and r = –0.44; P <0.01, respectively).
Consistent with the second hypothesis, we found the
following correlations: LORQv3 items, assessing psycho-
















n = 23 n = 8
SD Mean SD Mean SD
0.97 2.39 0.94 1.25 0.46
0.86 2.52 0.89 1.37 0.51
0.74 2.95 0.87 1.87 0.99
0.91 1.34 0.77 1.25 0.46
0.99 2.78 0.73 1.62 0.51
0.79 2.73 1.05 1.62 0.74
05, **P < 0.01. Post hoc comparisons using Dunn's test revealed following
p C, Group B vs Group C for item 26; Group B vs Group C for item 27; Group B
p B vs Group C for item 31.
















n = 9 n = 10 n = 7
Mean SD Mean SD Mean SD
If lower dentures or implant retained crown, bridges or
dentures (YES to question 32 or question 33)
34. Were you dissatisfied with your lower denture/implant
retained crown, bridges or dentures?
1.88 1.36 1.70 0.48 2.14 1.21
35. Did your lower denture/ implant retained crown,
bridges or dentures cause any soreness or injury to the
gum?**
1.22 0.44 2.20 0.42 3.00 0.81
36. Did food particles collect under your lower denture/
implant retained crown, bridges or dentures?**
1.33 0.50 3.10 0.32 3.00 0.82
37. Did you take out your lower denture/implant retained
crown, bridges or dentures for eating?
2.33 0.86 2.40 0.51 2.14 1.21
38. Did you feel unconfident with your lower denture/
implant retained crown, bridges or dentures?
1.33 0.50 1.80 0.42 1.71 0.75
39. Were you worried about your lower denture/implant
retained crown, bridges or dentures?**
1.77 0.44 3.00 0.82 2.71 0.48
SD, standard deviation; Kruskal-Wallis test for differences between 3 groups: **P < 0.01; Post hoc comparisons using Dunn's test revealed following significant
differences among groups at p <0.05 significance level: Group A vs Group B, Group A vs Group C, Group B vs Group C for item 35; Group A vs Group B, Group A
vs Group C for item 36; Group A vs Group B, Group A vs Group C for item 39.
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subscale of the UWQoLv4 than the items in the social-
emotional subscale.
Discussion
HRQOL has become an important outcome measure for
assessing and monitoring the impacts of oral rehabilita-
tion on the subjective well-being of patients with head
and neck cancer [5-11]. However, a small number of
studies have assessed the HRQOL using oral health spe-
cific and generic measures in Turkish patients with head
and neck cancer who had undergone oral rehabilitation
[28,29], whereas only one study has assessed HRQOL
using a targeted measure in patients with implant-
retained maxillofacial prostheses [30].
To the best of our knowledge, this is the first study to
evaluate the HRQOL using a head and neck function
specific measure in Turkish patients with head and neck
cancer.
As with many such instruments, this scale was devel-
oped in English and requires translation and validation
in Turkish if it is to be used in that language. In the
present study, the original LORQv3 was translated into
Turkish, following the recommendations of Beaton et al.
[19] and resulted in a back-translated version that was
very similar to the original, although word modifications
were made to take into account cultural differences.
In contrast to previous studies of the LORQv3 [15,16],
this study sample consisted of only head and neckcancer patients who had undergone prosthodontic treat-
ment at the Prosthodontics Clinic of our faculty, because
patients with head and neck cancer have very specific
needs that are beyond the needs of most other patients
diagnosed with other types of cancer.
The reliability analysis showed that all sections of the
LORQv3 showed satisfactory internal consistency, with
Cronbach’s alpha between 0.71 to 0.82. Our findings
are consistent with those of previous studies [15,16]. In
the test-retest reliability, kappa statistics for the 33
LORQ items ranged from 0.62 to 1.00, indicating good
reproducibility.
Construct validity was supported by comparing item
scores of the LORQv3 among patient groups consisting
of patients with maxillectomy and nasopharyngeal can-
cer without any maxillary defects. Patients who had
undergone mandibulectomy or glossectomy were not in-
cluded in this study, because the factors affecting
HRQOL in these patients were different from those in
the maxillectomy patients [31].
In patients with maxillectomy, obturators are import-
ant not only in rehabilitation and aesthetics, but also in
patient resocialization [5,6,8,9]. Consistent with previous
studies, we found that maxillectomy patients who re-
ceived adjuvant radiation experienced dry mouth [5], dif-
ficulties in mouth opening [8] and swallowing [8,10].
Supporting construct validity of LORQv3, we found
significant differences on the items regarding with being
concerned about appearance and the problems when
Table 7 Correlations between items of the LORQv3 and UW-QOL v4
LORQv3 Pain Appearance Activity Recreation Swallowing Chewing Speech Shoulder Taste Saliva Mood Anxiety
1. … difficulty chewing? -0.18 -,45** -,31* -0.27 -,32* -,55** -0.19 -0.15 -,37* -0.13 -0.21 0.04
2. … pain when you chew? -0.27 -0.24 -0.02 -0.04 -0.05 -,33* -0.04 -0.17 -0.18 -0.07 -0.19 -0.01
3. … difficulty swallowing solids? -,38** -,37* -,47** -,37* -,65** -,49** -,46** -0.17 -,37* -,41** -0.25 -0.13
4. … difficulty swallowing drinks? -,44** 0.09 -0.09 -0.11 -0.09 0.09 0.02 -0.18 -0.06 0.00 -0.21 -0.21
5. …particles collect under your tongue? -0.07 -0.04 -0.01 0.10 -0.11 -,38** 0.06 -0.26 -0.05 -,48** -0.02 0.12
6. …particles stick to your palate? 0.03 0.03 0.10 -0.08 0.09 0.08 ,33* -0.12 -0.02 -0.08 -0.22 0.04
7. …particles stick inside your cheeks? -0.01 0.08 0.14 -,37* -0.09 0.02 0.18 0.00 -0.05 0.07 0.12 0.10
8. …have mouth dryness? -0.06 -0.19 -,41** -0.23 -0.25 -0.26 -0.23 0.12 -0.22 -,48** -0.08 -0.03
9. ....saliva dribble out of the edge of your mouth -0.28 -,41** -0.23 -0.19 -0.16 -0.26 -,40** 0.02 -0.26 -0.26 -0.11 -,38**
10. . problems when speaking? -0.18 -,39** -0.23 -,36* -0.03 -0.24 -0.26 -0.01 -0.05 -0.16 -0.19 -,31*
11. . concerned by the appearance of your face? 0.04 -,49** -0.03 -0.24 0.21 -0.09 -0.10 0.28 0.03 0.13 -0.07 -0.06
12. . concerned by the appearance of your mouth? -0.12 -,51** -0.21 -0.27 -0.07 -0.25 -0.22 -0.04 -0.23 0.07 -,37* -0.09
13. .upset by the appearance of your lips? -0.28 -,44** -0.28 -0.24 -0.12 -,30* -0.19 0.05 -0.23 0.01 -0.18 -0.08
14. .upset by the appearance of your teeth? -0.21 -,30* -0.26 -0.23 -0.02 -0.20 -0.15 -0.03 -0.14 -0.03 -0.21 -0.03
15. . spending time with others in social activities..? -0.17 -,43** -0.25 -,39** -0.16 -,43** -,37* -0.16 -,34* -0.19 -,40** 0.01
16. . preference for some foods because of chewing …? -0.18 -,39* -0.24 -,30* -0.27 -,60** -,41** -0.28 -,48** -,35* -,30* 0.05
17. . experience difficulty with opening your mouth? -0.07 -0.27 -0.29 -0.19 -0.21 -0.17 -0.19 0.15 -0.20 -,32* -0.15 -0.03
20. . embarrassed talking with others… of your dentures/..? -,41** -,40** -,30* -,36* -0.05 -0.13 -,33* -0.07 -0.13 -0.08 -0.27 -0.14
21. . refuse dinner invitations……..about your dentures? -0.26 -,35* -,39** -,36* -,36* -0.23 -,36* -0.12 -,37* -0.29 -0.21 0.08
22. .loss of self confidence …….about your dentures/…? -0.06 -,44** -0.08 -,32* 0.18 -0.02 -0.08 0.16 0.02 0.06 -0.12 -0.09
23. .difficulty opening mouth because of you dentures/imp…? -0.21 -,29* -0.19 -0.10 -0.16 -0.21 -0.25 -0.01 -0.21 -,49** 0.09 0.02
26. . dissatisfied with your upper denture/…? -,41** -,40** -,30* -,36* -0.05 -0.13 -,33* -0.07 -0.13 -0.08 -0.27 -0.14
27. . cause any soreness or injury to the gum? -0.20 -0.20 -0.25 -0.26 -0.27 -0.21 -0.21 -0.01 -,34* -0.13 -0.08 -0.07
28. . particles collect under your upper denture/…? -,32* -,35* -,32* -0.28 -,42** -,30* -,38** -0.01 -,39** -0.27 -0.15 -0.04
29. . take out your upper denture/implant…? -0.16 0.00 -0.20 -0.05 -0.22 -0.04 -0.25 -,31* -0.06 -0.11 -0.08 0.08
30. . anxious with your upper denture/implant..? -0.22 -0.26 -0.25 -,32* -,30* -0.11 -0.27 -0.01 -0.26 -0.13 -0.07 -0.02
31. . worried about your upper denture/implant…? -0.11 -0.14 -0.12 -0.06 -0.12 -0.15 -0.15 0.01 -0.09 -,45** 0.15 0.02
34. . dissatisfied with your lower denture/ implant..? -,42* -0.31 -0.04 -0.03 -0.16 -0.18 -0.35 -,40* -0.17 0.07 -0.24 -0.19
35. . any soreness or injury to the gum…? -0.21 -0.25 -0.16 -0.20 -0.32 -,43* -0.37 -0.11 -,45* -,45* -0.03 0.26
36. . particles collect under your lower denture/…? -0.16 -0.15 -0.07 -0.03 -,43* -,52** -0.09 -0.05 -0.19 -,51** 0.04 0.21
37. . take out your lower denture/implant…? 0.18 -,44* -0.08 -0.27 -0.21 0.04 -0.18 0.04 -0.01 0.01 -0.35 -0.25
38. . unconfident with your lower denture….? -,40* -,42* -0.23 -0.31 -,39* -,46* -,44* -0.29 -0.34 -0.28 -,42* -0.17
39. . worried about your lower denture/implant…..? -0.18 -0.28 -0.04 -0.16 -0.29 -0.30 -0.24 -0.05 -0.22 -,40* -0.10 0.24
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pharyngeal cancer patients. Consistent with previous stud-
ies, maxillary obturator patients who received surgery
alone scored better than those who had been treated with
radiotherapy on three items: mouth dryness [5], difficulty
with swallowing solids [8,10,11] and opening the mouth
[8]. Maxillary obturator patients generally felt more dissat-
isfied and anxious than nasopharyngeal cancer patients. A
previous study [26] showed that oral cancer patients expe-
rienced more social problems than nasopharyngeal cancer
patients. Compared with nasopharyngeal cancer patients,
maxillary obturator patients who received surgery plus
radiotherapy felt more worried about their dentures and
reported having pain or gingival injury due to the dentures
and were the most likely to find food collecting under the
dentures. These findings may be explained by the fact that
functional challenges in patients with maxillectomy that
limit the ability to speak and eat are often apparent and
lead to social isolation, loss of employment, and decreased
quality of life [7,9,10]. In these patients, adjuvant radio-
therapy may result in greater self-reported oral and swal-
lowing problems [1,5,7,8].
We found no new items related to oral rehabilitation
because no participant provided free-text comments,
supporting content validity of the LORQv3.
Supporting its criterion validity, significant negative
correlations were observed for some related items be-
tween the LORQv3 and the UW-QOL v4, which are in
line with the results of a previous study [15]. Items of
the LORQv3, assessing the psychosocial function and
patient satisfaction correlated better with the items on
the physical subscale of the UW-QOL v4 than with its
items on the social–emotional function subscale. This
finding is not surprising, because the study sample in-
cluded predominantly maxillectomy patients, rehabilitated
with obturator. Previous studies showed that inadequate
orofacial functions, essential for social well being, that are
affected by obturator stability and retention are the most
important problems faced by maxillectomy patients reha-
bilitated with obturator [5,9,10]. These findings support
the concept of using a head and neck specific question-
naire as an indicator of oral function.
There are some limitations to this study. This study in-
volved a small cohort of patients comprised of patients
with maxillary sinus and nasopharyngeal cancer. Future
studies are needed to evaluate psychometric properties of
the LORQv3 in both patients diagnosed with other types
of head and neck cancer and non-cancer patients. The
cross-sectional design did not allow causation or changes
over time in patients’ HRQOL to be studied. Future clin-
ical and longitudinal studies using the LORQv3 may pro-
vide valuable information for the maxillofacial prosthetic
team in assessing self-perceived change of HRQOL in
these patients.Despite these limitations, this study has strengths.
Firstly, a sample size was calculated based on the test–
retest reliability in accordance with a recent systematic
review of validation studies of cancer patients under pal-
liative care [32]. It is known that the ability of a measure
to be responsive to change depends upon test-retest reli-
ability and better reproducibility, suggesting more pre-
cise single measurements, which is a requirement for
better tracking of changes in measurements in clinical
practice settings [32,33]. Secondly, patients who had
continuing or recurrent disease were excluded from the
study, because retested patients must be in a stable con-
dition with respect to the construct to be measured by
the HRQOL measures [2,32]. Lastly, the appropriate
time interval of two weeks was chosen because it de-
pends on the construct to be measured and the target
population [14,16,32].Conclusion
Within the limitations of this study, the Turkish version
of LORQv3 appears to be a valid and reliable tool for
assessing the impact of oral rehabilitation on the
HRQOL of patients with head and neck cancer; it can
also be used in clinical investigations and routine clinical
practice.
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